OFI Invest Asset Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$34.1M Sell
307,767
-12,567
-4% -$1.66M 0.34% 68
2026
Q1
$38.9M Sell
320,334
-528,943
-62% -$74.1M 0.51% 43
2025
Q4
$88.8M Buy
849,277
+470,804
+124% +$57.2M 1.27% 15
2025
Q3
$35.8M Buy
378,473
+182,243
+93% +$20.7M 0.75% 41
2025
Q2
$18.5M Sell
196,230
-86,817
-31% -$9.24M 0.46% 61
2025
Q1
$29.4M Buy
283,047
+1,425
+0.5% +$147K 0.77% 44
2024
Q4
$25.1M Buy
+281,622
New +$25.4M 0.59% 52
2024
Q2
$29.9K Buy
467
+100
+27% +$6.67K ﹤0.01% 330
2024
Q1
$24.9K Buy
367
+11
+3% +$846 ﹤0.01% 281
2023
Q4
$26.1K Sell
356
-5
-1% -$389 ﹤0.01% 247
2023
Q3
$25.6K Buy
+361
New +$27.8K ﹤0.01% 190
2023
Q2
Sell
-233,229
Closed -$2.81M 122
2023
Q1
$2.81M Buy
+233,229
New +$19.3M 0.01% 107

Other funds holding GILD

OFI Invest Asset Management's GILD Position: Q2 2026 in Review

OFI Invest Asset Management reduced its Gilead Sciences (GILD) stake by 3.9% in Q2 2026, selling an estimated $1.66M and leaving 307,767 shares worth $34.1M. The position accounts for 0.34% of the portfolio, ranked #68.

OFI Invest Asset Management first reported a position in GILD in Q1 2023 and has held it in 12 quarters since. The position peaked at $88.8M in Q4 2025. 768 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • OFI Invest Asset Management held 307,767 shares of Gilead Sciences worth $34.1M as of Q2 2026.
  • OFI Invest Asset Management sold 12,567 Gilead Sciences shares in Q2 2026, an estimated $1.66M.
  • Gilead Sciences made up 0.34% of OFI Invest Asset Management's portfolio in Q2 2026, its #68 holding.
  • OFI Invest Asset Management first reported a position in Gilead Sciences in Q1 2023 and has held it in 12 quarters since.
  • OFI Invest Asset Management's Gilead Sciences position peaked at $88.8M in Q4 2025.
  • 768 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on OFI Invest Asset Management's 13F filing for Q2 2026, filed 17 Jul 2026.